Jon Stamford

1.8k total citations
37 papers, 1.4k citations indexed

About

Jon Stamford is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Jon Stamford has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 12 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Jon Stamford's work include Neuroscience and Neuropharmacology Research (12 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Jon Stamford is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Jon Stamford collaborates with scholars based in United Kingdom, United States and Netherlands. Jon Stamford's co-authors include Christine Jorm, Zygmunt L. Kruk, R. M. Langford, Colin Davidson, Sarah E. Hopwood, Jane Millar, Peter Palij, P.P.A. Humphrey, Michael J. Sheehan and Pamela Hancock and has published in prestigious journals such as Brain Research, Neuroscience and Neuropharmacology.

In The Last Decade

Jon Stamford

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Stamford United Kingdom 20 584 310 280 215 198 37 1.4k
Kory Schuh United States 27 317 0.5× 435 1.4× 312 1.1× 665 3.1× 48 0.2× 58 2.4k
Atul C. Pande United States 20 434 0.7× 238 0.8× 289 1.0× 274 1.3× 122 0.6× 36 2.1k
Charles G. Lineberry United States 16 369 0.6× 145 0.5× 157 0.6× 250 1.2× 84 0.4× 30 1.4k
Josimari Melo DeSantana Brazil 23 116 0.2× 688 2.2× 98 0.3× 199 0.9× 204 1.0× 91 1.9k
Lawrence Adler United States 18 193 0.3× 106 0.3× 305 1.1× 298 1.4× 105 0.5× 30 1.3k
Amir Garakani United States 19 268 0.5× 121 0.4× 200 0.7× 177 0.8× 247 1.2× 62 1.7k
Roland W. Freudenmann Germany 27 218 0.4× 111 0.4× 149 0.5× 358 1.7× 92 0.5× 94 2.4k
Stefan Bleich Germany 25 385 0.7× 197 0.6× 319 1.1× 254 1.2× 88 0.4× 71 1.6k
Jun Ishigooka Japan 24 196 0.3× 96 0.3× 241 0.9× 223 1.0× 116 0.6× 123 1.6k
Kenneth G. Walton United States 24 281 0.5× 246 0.8× 432 1.5× 200 0.9× 42 0.2× 57 2.0k

Countries citing papers authored by Jon Stamford

Since Specialization
Citations

This map shows the geographic impact of Jon Stamford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Stamford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Stamford more than expected).

Fields of papers citing papers by Jon Stamford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Stamford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Stamford. The network helps show where Jon Stamford may publish in the future.

Co-authorship network of co-authors of Jon Stamford

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Stamford. A scholar is included among the top collaborators of Jon Stamford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Stamford. Jon Stamford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alonso‐Cánovas, Araceli, et al.. (2022). The silver linings of Parkinson’s disease. npj Parkinson s Disease. 8(1). 21–21. 3 indexed citations
2.
Riggare, Sara, Jon Stamford, & Maria Hägglund. (2021). A Long Way to Go: Patient Perspectives on Digital Health for Parkinson’s Disease. Journal of Parkinson s Disease. 11(s1). S5–S10. 23 indexed citations
3.
Mursaleen, Leah, et al.. (2017). Descriptive symptom terminology used by Parkinson’s patients and caregivers. Volume 7. 71–78. 1 indexed citations
4.
Lakshminarayana, Rashmi, Duolao Wang, David J. Burn, et al.. (2017). Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson’s disease. npj Parkinson s Disease. 3(1). 77 indexed citations
5.
Stamford, Jon, D. Scheller, & Peter Jenner. (2016). Parkinson’s Inside Out. Journal of Parkinson s Disease. 6(1). 65–66. 1 indexed citations
6.
Mathur, Soania, et al.. (2015). Rising to the Challenges of Clinical Trial Improvement in Parkinson’s Disease. Journal of Parkinson s Disease. 5(2). 263–268. 29 indexed citations
7.
8.
Wicks, Paul, Jon Stamford, Martha A. Grootenhuis, Lotte Haverman, & Sara Ahmed. (2013). Innovations in e-health. Quality of Life Research. 23(1). 195–203. 97 indexed citations
9.
McLaughlin, Daniel P., Jon Stamford, David A. White, & Terence Bennett. (2007). Instant notes human physiology. Taylor & Francis eBooks. 1 indexed citations
10.
Toner, C. C., Kim A. Connelly, Robin Whelpton, et al.. (2001). Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. British Journal of Anaesthesia. 86(4). 550–554. 40 indexed citations
11.
Callado, Luís F., Colin Davidson, Paul E. M. Phillips, et al.. (2000). Propofol decreases stimulated dopamine release in the rat nucleus accumbens by a mechanism independent of dopamine D2, GABAA and NMDA receptors. British Journal of Anaesthesia. 84(2). 250–253. 23 indexed citations
12.
Callado, Luís F., et al.. (1999). Effects of tramadol stereoisomers on norepinephrine efflux and uptake in the rat locus coeruleus measured by real time voltammetry. British Journal of Anaesthesia. 83(6). 909–915. 49 indexed citations
13.
Hancock, Pamela & Jon Stamford. (1999). Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens. British Journal of Anaesthesia. 82(4). 603–608. 45 indexed citations
14.
Davidson, Colin, et al.. (1997). Actions of tramadol, its enantiomers and principal metabolite, O-desmethyltramadol, on serotonin (5-HT) efflux and uptake in the rat dorsal raphe nucleus. British Journal of Anaesthesia. 79(3). 352–356. 141 indexed citations
15.
Jorm, Christine & Jon Stamford. (1995). Actions of morphine on noradrenaline efflux in the rat locus coeruleus are mediated via both opioid and α2 adrenoceptor mechanisms. British Journal of Anaesthesia. 74(1). 73–78. 14 indexed citations
16.
Stamford, Jon. (1992). Monitoring neuronal activity : a practical approach. Oxford University Press eBooks. 47 indexed citations
17.
Hafizi, Sepehr, Peter Palij, & Jon Stamford. (1992). Activity of two primary human metabolites of nomifensine on stimulated efflux and uptake of dopamine in the striatum: In vitro voltammetric data in slices of rat brain. Neuropharmacology. 31(8). 817–824. 13 indexed citations
18.
Palij, Peter, Michael J. Sheehan, Jane Millar, et al.. (1990). Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. Journal of Neuroscience Methods. 32(1). 37–44. 82 indexed citations
19.
Palij, Peter, David Bull, Michael J. Sheehan, et al.. (1990). Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Brain Research. 509(1). 172–174. 83 indexed citations
20.
Marsden, C.A., M. H. Joseph, Zygmunt L. Kruk, et al.. (1988). In vivo voltammetry—Present electrodes and methods. Neuroscience. 25(2). 389–400. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kory Schuh Breakdown of academic impact, for papers by Atul C. Pande Breakdown of academic impact, for papers by Charles G. Lineberry Breakdown of academic impact, for papers by Josimari Melo DeSantana Breakdown of academic impact, for papers by Lawrence Adler Breakdown of academic impact, for papers by Amir Garakani Breakdown of academic impact, for papers by Roland W. Freudenmann Breakdown of academic impact, for papers by Stefan Bleich Breakdown of academic impact, for papers by Jun Ishigooka Breakdown of academic impact, for papers by Kenneth G. Walton
Rankless by CCL
2026